ArticleThe European physical journal. E, Soft matter2026
Endophytic fungi of Aegle marmelos as a source of novel antibacterials and anti-SARS-CoV agents.
Article in The European physical journal. E, Soft matter, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug resistance in microorganisms is a growing global threat, highlighting the urgent need for novel therapeutic agents. This study evaluates the antibacterial and anti-SARS-CoV potential of fungal endophytes isolated from A. marmelos. Among 16 endophytes screened, the ethyl acetate extract of the #3 AMLBF strain (Fusarium vanettenii) exhibited the strongest antibacterial activity against several pathogens. This extract showed minimum inhibitory concentrations (MICs) ranging from 0.49 to 0.8 µg/ml. GC/MS analysis of the active extract identified 45 compounds. Furthermore, molecular docking against the SARS-CoV-2 spike glycoprotein revealed nine potential ligands, with Anthraergosta-5,7,9,22-tetren-3-ol p-chlorobenzoate showing the most potent binding affinity (- 10.2 kcal/mol), a value exceeding that of the standard chloroquine (- 6.5 kcal/mol). These results indicate that the organic extract from this fungal strain is a promising candidate for the discovery of new antimicrobial agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.